Threat of compulsory licences could increase access to essential medicines

In an analysis, published in The BMJ, Gorik Ooms and Johanna Hanefeld argue that low- and middle-income countries could increase access to medicines by forming an alliance to credibly threaten companies with compulsory licences.

Read the full analysis here.

To subscribe to the Weekly Newsletter of new posts, enter your email here:


By Gorik Ooms and Johanna Hanefeld

Published: June 2, 2019, 9 p.m.

Last updated: June 2, 2019, 9:01 p.m.

Tags: Access

Print Share